Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

KVB

K V Pharma CL B (KVB)

K V Pharma CL B
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:KVB
DataHoraFonteTítuloCódigoCompanhia
18/06/201210:04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
16/11/201123:15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
02/11/201123:40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
31/10/201123:30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
28/10/201118:30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
24/10/201115:52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
13/06/201109:00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVBK V Pharma CL B
01/04/201116:08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVBK V Pharma CL B
01/04/201111:28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVBK V Pharma CL B
31/03/201118:28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVBK V Pharma CL B
30/03/201116:58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
30/03/201113:38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
01/03/201110:49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVBK V Pharma CL B
14/02/201113:34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVBK V Pharma CL B
14/02/201112:48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVBK V Pharma CL B
04/02/201111:40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVBK V Pharma CL B
12/01/201112:03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™NYSE:KVBK V Pharma CL B
14/09/201011:29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVBK V Pharma CL B
10/09/201010:53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVBK V Pharma CL B
20/01/201018:41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVBK V Pharma CL B
20/01/201017:11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVBK V Pharma CL B
11/01/201012:18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVB
07/01/201019:10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVB
15/12/200920:26PR Newswire (US)KV Pharmaceutical Sets Record Date for Stockholder Action by Written ConsentNYSE:KVB
02/12/200919:45PR Newswire (US)KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van VlietNYSE:KVB
13/11/200919:01PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw AmendmentsNYSE:KVB
07/10/200914:54Dow Jones NewsLarge Generic Drug Cos Benefiting From Price StabilityNYSE:KVBK-V Pharmaceutical Co. (Cl B)
21/09/200909:30PR Newswire (US)KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)NYSE:KVB
15/09/200917:34PR Newswire (US)KV Pharmaceutical Receives Stockholder Action by Written ConsentNYSE:KVB
04/09/200918:43PR Newswire (US)KV Pharmaceutical Appoints Interim Chief Financial OfficerNYSE:KVB
 Apresentando as notícias mais relevantes sobre:NYSE:KVB